Studies
List of Studies being conducted at CARE
Maritime-1
In Follow Up, Weight Loss
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight…
Transform
Enrolling
The Transform trial is utilizing CCTA technology to develop a plaque staging software system for asymptomatic individuals at increased risk…
Comet
Enrolling, Heart Failure
This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping…
Pfizer Obesity
Weight Loss, In Follow Up
This study is looking at a once daily pill (PF-07976016) in combination with Liraglutide which is an approved GLP-1R agonist in patients…
MUIR-3
In Follow Up, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…
Redefine-3
In Follow Up, Weight Loss
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…
Shasta-4
In Follow Up, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…
Triumph
In Follow Up, Weight Loss
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and chronic…
BalanceD-HF
Enrolling, Heart Failure
The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…
V-Prevent
In Follow Up, Cholesterol
The purpose of this study is to evaluate inclisiran sodium 300 mg s.c. (equivalent to 284 mg inclisiran) compared to placebo on reducing the…
Acclaim
Enrolling, Lipoprotein (a)
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…
Tharros
Enrolling, COPD
THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…